It is believed that Terminalia chebula can destroy all diseases and eliminate all waste from the body, and also promote tissue growth and health.
Terminalia chebula is also powerful adaptogenic agent and is one of those three herbs that make the winning combination in Ayurvedic science called ‘triphala’ being followed by two other herbs – bibhitaki and aamlaki. In Ayurvedic medicine, Terminalia chebula is highly regarded for its over-the-top healing powers.
In India, Terminalia chebula is used to treat many conditions like digestive disorders, irregular fevers, flatulence, constipation. It is the best bowel cleanser and can be helpful emptying the stomach in a safer way.
Terminalia cheubla is basically astringent, mild and safe purgative, stomachic and mild laxative. It has been used to treat various conditions particularly asthma, piles and cough. It is also useful in healing of wounds and scalds. Haritaki can be used as gargle against inflammation of mucous membrane in the mouth.
Terminalia cheubla is also used for treating ulcers, vomiting, colic pain urinary infections, diabetes, skin diseases, parasitic infections, heart diseases, and hemorrhoids. Terminalia cheubla, if taken after meals, prevents stomach upset. Preliminary researches have shown that Terminalia chebula is very effective in treating the herpes simplex virus (HSV). However, safety of the drug in pregnancy lacks of researches and have not established firmly.
Other clinical trials show that Terminalia chebula has anti-tumor activity and it possesses favorable effect in inhibiting the HIV virus up to certain extent. Out of all, here are some of the prime indications where it gets you best results –
- It is best mild laxative so work in cleansing the bowels
- It is best adaptogenic agent and hence best general health tonic
- It is a safe astringent agent
| Packs |
Retail Price |
Shipping |
Order Now |
 |
 |
 |
 |
|
Serving size: 2 Vegi caps
Servings per container: 30
Each 500 mg capsule contains: Haritaki
Dosage: 1-2 Capsules two times a day after meal or or as directed by your health practitioner.
Terminalia chebula exhibited antibacterial activity against a number of bacterial species. One group of researchers revealed that it is effective in inhibiting the urease activity of Helicobactor pyroli (H. pyroli), a ubiquitous bacterium implicated in the development of gastritis, ulcers and stomach cancers. Antibacterial activity of Terminalia chebula against both; Gram positive and Gram negative human pathogenic bacteria has also been recorded. Gallic acid
and its ethyl ester isolated from ethanolic extract of Haritaki showed antimicrobial action against methicillin-resistant Staphylococcus aureus. Diffusate of Haritaki featured an inhibitory effect against strain XC-100 of the bacterium Xanthomonas Campestris pv. Citri, indicating its efficacy to manage citrus canker disease. The herb also possesses inhibitory action against Salmonella typhi and other intestinal bacteria.
Researches show that an aqueous extract of Haritaki exhibits antifungal activity against a number of dermatophytes and yeasts. It is useful against the pathogenic yeast Candida albicans, dermatophytes Epidermophyton, Floccosum, Microsporum gypseum and Trichophyton rubrum. Its inhibitory effect on three dermatophytes (Trichophyton spp.) and three yeasts (Candida spp.) has also been recorded
Terminalia chebula fruits yielded four immunodeficiency virus type 1 (HIV-1) integrase inhibitors, gallic acid and three galloy glucoses. Their galloyl moiety plays important role in inhibiting the 3'–processing of HIV-1 integrase of the compounds. Terminalia chebula also features retroviral reverse transcriptase inhibitory activity. The herb protects epithelial cells against influenza A virus, supporting its traditional use for assisting in recovery from acute respiratory infections. It also showed a substantial inhibitory activity on the effects of immunodeficiency virus- 1-transcriptase.
Terminalia chebula has also established therapeutic activity against Herpes Simplex Virus (HSV) both in vitro and in vivo tests. These findings prompted a team of Japanese researchers to evaluate Terminalia chebulas’s effect on human cytomagalovirus (CMV). They found that Terminalia chebula was very effective in suppressing the replication of human cytomagalo virus in vitro and in an AIDS model mice with immunosupresssion and concluded that it may be useful for the prevention of CMV diseases and immonocompronised patients.
The herb works wonderfully when applied to local area in various health ailments. Haritaki’s paste with water is found to be good anti-inflammatory agent. It is also analgesic and has purifying cum healing properties. The herb is therefore useful in wounds. The decoction made out of the herb can be used as a surgical dressing for healing the wound quickly.
Equal parts of three myroblanas and and catechu are made into paste with clarified butter (you can also take some bland oil) will work as an ointment in chronic ulceration, ulcerated wounds and other skin problems having any kind of discharge.
Astringent properties of the herbs can be used for the purpose treating hemorrhoids. The decoction of Haritaki can be used as gargling for oral ulcers and sore throats. One can also apply powder of the herb to the gums so that it ceases bleeding and development of bacteria within the oral cavity.
Antimutagenic activity of hydrolyzable tannins from Haritaki in Salmonella typhi has been listed. A group of researchers have revealed the inhibitory action on cancer cell growth by the phenolics of Haritaki Retz fruit and discovered that chebulinic acid, tannic acid and ellagic acid were the most growth inhibitory phenolics of the herb. Besides, acetone extract of bark and fruit powder of herb, harbors constituents are with assuring antimutagenic/ anticarcinogenic activity.
Six extracts and four compounds of the herb Haritaki fruit exhibited antioxidant activity at different magnitudes of potency. Terminalia’s fruit exerts antioxidant and radio-protective activity in mice. Protective effects of an aqueous
extract of Haritaki fruit on the tert-butyl hydroperoxide (t-BHP)-induced oxidative injury was discovered in cultured rat primary hepatocytes and rat liver have also been listed. It possessed stronger antioxidant activity as compared to alpha-tocopherol; HPLC analysis with diode array detection revealed that the presence of hydroxybenzoic acid derivatives, hydroxycinnamic acid derivatives, flavonol aglycones and their glycosides, as main phenolic compounds.
Adaptogenic and antianaphylactic activities of Haritaki fruit was one of the six Ayurvedic herbs administered to animals to evaluate their adaptogenic potency. All six traditional rasayana (rejuvenating herbs) plants were able to aid the animals against a variety of different stressors working in different degrees. Besides, animal studies revealed that when extract of Terminalia chebula was given following induction of anaphylactic shock, the serum histamine levels were reduced showing its strong anti-anaphylactic action
Haritaki is great anti-inflammatory and astringent agent. It is therefore useful in urethral discharges such as spermatorrhea, vaginal discharges like leucorrhea. The herb can also be given as adjuvant in atonic conditions of uterus.
Hypolipidemic activity of the herb Haritaki extract against experimentally induced atherosclerosis has been recorded. It also possessed hypocholesterelomic action against cholesterol-induced hypercholesterolemia and atherosclerosis in rabbits. The herb improves gastrointestinal motility and has anti-ulcerogenic activity. The Haritaki fruit has been considered to be great gastric emptying agent. This action seemed to be balanced with its protective effect on the gastrointestinal mucosa, with an improvement in the secretory status of Brunner’s gland that is mainly involved in protecting against duodenal ulcer.
Terminalia chebula extract was discovered to prevent the hepatotoxiocity caused due to administration of rifampicin (RIF), isoniazid (INH) and pyrazinamide (PZA) (combination) in sub-chronic model (twelve weeks). The extract showed great recovery of the hepatocytes.
Cardio-protective activity of Haritaki extract pretreatment was found to
ameliorate the effect of isoproterenol on lipid peroxide formation and held the activities of the diagnostic marker enzymes in isoproterenol induced myocardial damage in mice. Its pericap has also been proven to have cardio-protective action in isolated frog heart model. Cytoprotective activity of Gallic acid (GA) and Chebulic acid (CA) were disjointed from the extract of the herbal medicine Kashi (myrobalan, the fruit of Terminalia chebula) as active principal that banned the cytotoxic T- lyphocyte (CTL)-mediated cytotoxicity.
The administration of the Haritaki or Terminalia chebula extract prior to whole body irradiation of rat resulted in a reduction of peroxidation of membrane lipids in the rat’s liver as well as a diminish in radiation induced damage to its DNA. It also protected the human lymphocytes from changing with the gamma radiation-induced damage to DNA exposed in-vitro study.
Haritaki or Terminalia chebula fruit displayed dose dependent reduction in blood glucose of streptozotocin induced diabetic mice both; in short term as well as in long term study. It also showed retina protection action along with antispasmodic activity. One of the researches of Haritaki revealed its anti-spasmodic actions by the reducing the abnormal blood pressure as well as intestinal cramps. This confirms its traditional use for spastic colon and other intestinal disturbances.
Haritaki is a large tree with young branchlets and leaf buds. The tree’s leaves are- mostly sub-opposite, distant, and ovate along with long, soft, shining, rust colored or silvery hairs. It gets wither in the cold season. The flowers of the haritaki are dull white or yellowish, with a strong offensive smell. They blossom in the month of April to May. Fruits of haritaki are obovoid or ellipsoidal from a broad base glabrous. Their formations occur in the month of November to January.
Supplement Facts:
Serving size: 2 Vegi caps
Servings per container: 30
Each 500 mg capsule contains: Haritaki
Dosage: 1-2 Capsules two times a day after meal or or as directed by your health practitioner
| Packs |
Retail Price |
Shipping |
Order Now |
 |
 |
 |
 |
|
|
|